title: Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
abstract: The objective of this research was to develop and evaluate sustained-release matrix tablets of BKP-01-041 (tilorone derivative) based on Hypromellose (hydroxypropyl methylcellulose, HPMC) as the matrix forming polymer. The sustained-release tablets were prepared by the wet granulation method. The influence of HPMC viscosity and ratios on drug release was investigated in vitro. Dissolution of the tablets developed with 26% HPMC K4 M/K100 M (1:2) (w/w) content showed a better drug release profile than the other batches tested in 12 h. Drug release from the optimal formulation was analyzed using release kinetics equations. The release kinetics parameters were determined and the value of the exponent (n) representing the apparent drug release mechanism determined from the Peppas equation was about 0.726. These results suggest that the drug release mechanism was non-Fickian (0.45 < n < 0.89), and drug release was dependent on both drug diffusion and polymer erosion.
authors.affiliation: Tianjin Medical University, No. 220, Dongting Road, 300 457 Tianjin, PR China. cliangmei@gmail.com
authors.forename: Liangmei
authors.initials: L
authors.lastname: Chen
authors.forename: Fei
authors.initials: F
authors.lastname: Wang
mesh_terms: D000465:Algorithms; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D005079:Excipients; D065347:Hypromellose Derivatives; D007700:Kinetics; D008747:Methylcellulose / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D011208:Powders; D012995:Solubility; D013994:Tilorone / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000737:chemistry
chemical_list: C585597:BKP-01-041; D003692:Delayed-Action Preparations; D005079:Excipients; D011208:Powders; D065347:Hypromellose Derivatives; D008747:Methylcellulose; D013994:Tilorone